Randomised, double-blind, placebo controlled pilot study assessing nitroglycerin as a tocolytic
- PMID: 10428533
- DOI: 10.1111/j.1471-0528.1999.tb08376.x
Randomised, double-blind, placebo controlled pilot study assessing nitroglycerin as a tocolytic
Abstract
Thirty-three women in preterm labour were randomised in a double-blind fashion to receive either transdermal nitroglycerin (n = 17) or placebo (n = 16). Both groups had significant (P < 0.001) change in the cervix prior to randomisation. The primary outcome measure was delivery within 48 hours of randomisation. Fewer women randomised to nitroglycerin treatment (6/17) were delivered within 48 hours, compared with the placebo treatment (10/16) (RR 0.56, 95% CI 0.27 to 1.19). This pilot study lends support to two case series published that suggest that transdermal nitroglycerin may be promising as a safe, effective means for tocolysis.
Comment in
-
Randomised, double-blind, placebo controlled pilot study assessing nitroglycerin as a tocolytic.BJOG. 2000 Sep;107(9):1182-3. doi: 10.1111/j.1471-0528.2000.tb11132.x. BJOG. 2000. PMID: 11002973 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical